Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,650.00
Ask: 1,710.00
Change: 0.00 (0.00%)
Spread: 60.00 (3.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Dec 2012 07:25

AMEC: Credit Suisse reduces target price from 1300p to 1250p reiterating an outperform rating.Anglo American: Barclays upgrades to equal-weight with a target price of 1970p.Ashtead Group: Barclays raises target price from 352p to 434p and reiterates an overweight rating.ASOS: HSBC raises target price from 2590p to 2750p and keeps a neutral rating. Barclays raises target price from 3000p to 3100p maintaining an overweight rating.AstraZaneca: Deutsche Bank raises target price from 2880p to 2970p; hold rating remains unchanged.BAE Systems: Deutsche Bank moves target price from 340p to 350p reiterating a buy recommendation.Cookson Group: Citigroup downgrades to neutral with a target price of 650p.Diageo: Barclays reduces target price from 2050p to 2020p keeping its overweight rating. Nomura cuts target price from 2100p to 2070p and reiterates its buy recommendation.GlaxoSmithKline: Deutsche Bank moves target price from 1400p to 1440p and maintains a hold recommendation. Panmure Gordon raises target price from 1450p to 1500p and upgrades from hold to buy. Credit Suisse moves target price from 1430p to 1420p keeping a neutral rating.ICAP: Credit Suisse reduces target price from 350p to 320p and downgrades from outperform to neutral.IDOX: Investec raises target price from 47p to 60p and keeps its buy recommendation.IG Group: UBS cuts target price from 525p to 505p; buy rating kept.Lonmin: Credit Suisse upgrades to outperform with an target price of 525p.Meggitt: Deutsche Bank raises target price from 425p to 445p; buy recommendation unchanged.Mothercare: UBS raises target price from 230p to 250p and retains a sell recommendation.Redefine International: Peel Hunt downgrades to hold.Rolls-Royce Group: Deutsche Bank raises target price from 790p to 870p and keeps a hold recommendation.Senior: Jefferies moves target price from 233p to 236p, while keeping a buy recommendation.Shire Pharmaceuticals: Credit Suisse raises target price from 2180p to 2250p and keeps an outperform rating.Stratex International: Northland Capital reduces target price from 17.10p to 12.80p maintaining its buy recommendation.TUI Travel: Alphavalue raises target price from 260.30p to 346.40p and upgrades to buy.Tullow Oil: UBS cuts target price from 1400p to 1250p and keeps a neutral rating. Deutsche Bank reduces target price from 1180p to 1155p reiterating a hold recommendation. Barclays cuts target price from 1895p to 1845p, while maintaining an overweight rating. Credit Suisse reduces target price from 1550p to 1480p and downgrades from outperform to neutral. WH Ireland reduces target price from 1592p to 1515p, while keeping its buy recommendation. Liberum Capital moves target price from 1800p to 1760p and retains a buy rating.Ultra Electronics Holdings: Deutsche Bank downgrades to sell, while retaining target price at 1400p.Unilever: UBS raises target price from 2400p to 2590p, while maintaining its buy recommendation.Victrex: JP Morgan raises target price from 1160p to 1500p keeping a neutral rating. HB Markets upgrades to buy.Whitbread: JP Morgan raises target price from 2500p to 2650p; overweight rating remains unchanged.WPP Group: JP Morgan raises target price from 1004p to 1054p and retains an overweight rating.
More News
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.